Combination Pharmacology for ALS: A Mechanistic Rationale
International Journal of Molecular Sciences · 19.08.2026 · 27 (16) · 7404
DOI: 10.3390/ijms27167404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.08.2026. Verfasst von Jeffrey Rosenfeld und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Restorative Neurology, Department of Neurology, Loma Linda University Health, Loma Linda, CA 92354, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) involves multiple converging pathogenic mechanisms, including glutamate excitotoxicity, oxidative and endoplasmic-reticulum stress, mitochondrial dysfunction, neuroinflammation, iron dysregulation, and altered microRNA processing. Expecting a single pharmacologic intervention to meaningfully alter such a complex disease has proven overly optimistic and is reflected by the modest clinical benefits of approved monotherapies. This review outlines the mechanistic foundation and translational rationale for combination pharmacology in ALS. Drawing from paradigms in oncology, infectious disease, and other neurological disorders, it explores how rational multi-target strategies, whether synergistic, complementary, or pathway-divergent, may better address the multifactorial biology of ALS. The review also discusses recent mechanistic examples and design principles for advancing this therapeutic paradigm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Restorative Neurology, Department of Neurology, Loma Linda University Health, Loma Linda, CA 92354, USA.
- NeuroSense Therapeutics, Herzliya 4672562, Israel.
ORCID-Profile: Jeffrey Rosenfeld, Shiran Salomon-Zimri
Zitieren
APA
Rosenfeld, J., Salomon-Zimri, S., & Tracik, F. (2026). Combination Pharmacology for ALS: A Mechanistic Rationale. International Journal of Molecular Sciences, 27(16), 7404. https://doi.org/10.3390/ijms27167404
Vancouver
Rosenfeld J, Salomon-Zimri S, Tracik F. Combination Pharmacology for ALS: A Mechanistic Rationale. International Journal of Molecular Sciences. 2026;27(16):7404. doi:10.3390/ijms27167404
BibTeX
@article{Rosenfeld2026,
author = {Rosenfeld, Jeffrey and Salomon-Zimri, Shiran and Tracik, Ferenc},
title = {Combination Pharmacology for ALS: A Mechanistic Rationale},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7404},
doi = {10.3390/ijms27167404}
}
EUVIMED